Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Biomedical Engineer Presents Important Findings on the Responsiveness of Standing CT for Measurement of Knee Joint Space Narrowing at IOWAI 2018

Imaging is a critical tool in the diagnosis and management of osteoarthritis. The International Workshop on Osteoarthritis Imaging (IOWAI) was created to offer opportunities for osteoarthritis investigators to discuss issues and share findings related to imaging. This Workshop was first held in Ainring, Germany in 2017 and is now held annually at various locations in Europe and…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want MarketScale to feature Healthcare?

Book a 15-minute demo and we'll map your Healthcare expertise to the content buyers are searching for.

Book a demo

Imaging is a critical tool in the diagnosis and management of osteoarthritis. The International Workshop on Osteoarthritis Imaging (IOWAI) was created to offer opportunities for osteoarthritis investigators to discuss issues and share findings related to imaging. This Workshop was first held in Ainring, Germany in 2017 and is now held annually at various locations in Europe and North America. This year’s IOWAI will be held in Menton, France, on July 5-8. Thought leaders and influencers from academia, regulatory and funding agencies, and the medical equipment industry will be in attendance.

Kaitlin Rabe, Biomedical Research Assistant at the University of Kansas Medical Center, will be presenting a poster titled, “Responsiveness of Standing CT for Measurement of Knee Joint Space Narrowing Over 60 Months.” The study was sponsored by the National Institutes of Health, the University of Iowa, and the University of California, San Francisco.

In the workshop, Ms. Rabe will discuss the limitations of two-dimensional radiography when measuring joint space width (JSW). These 2D weight-bearing radiographs traditionally suffer from poor sensitivity when used to detect knee osteoarthritis and produce poor correlation with symptom progression.

Much of these issues can be attributed to the inherent limitations in the 2D radiography procedure, such as the dependence on X-ray beam alignment with the medial tibial plateau. In addition, the temporal and spatial heterogeneity of structural progression of knee OA limits the responsiveness of radiographic JSW to diagnose disease progression. MRI offers important advantages over 2D radiography, but is typically non-weight-bearing.

Standing CT (SCT) imaging holds the potential to overcome these limitations and enhance responsiveness in three-dimensional JSW measurements. This is because JSW is measured in a loaded position while avoiding bony overlap and error due to beam angle variations.

In her workshop, Ms. Rabe will provide preliminary data for the responsiveness of 3D JSW on SCT over 60 months using an early prototype of the CurveBeam LineUP system. The LineUP is a compact, ultra-low dose Cone Beam CT imaging system specifically designed for the orthopedic and podiatric specialties. Preliminary data calculated for 33 knees from 19 participants over 60 months support the hypothesis that 3D JSW exhibits a greater responsiveness than has been reported for radiography, similar to that for quantitative cartilage thickness measured on MRI over 12-months.

To get all the details on this important study, be sure to attend Ms. Rabe’s workshop at the IOWAI in Menton, France, July 5-8. For more details on accommodations and the all the workshops at this important conference, go to https://www.iwoai.org/.

Read more at curvebeam.com

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Medicare's ACCESS pilot is live, but patients can't find which providers offer it

Medicare's ACCESS pilot is live, but patients can't find which providers offer it

The Centers for Medicare & Medicaid Services (CMS) launched its tech-enabled chronic care pilot program, known as the ACCESS pilot. Despite its initiation, a significant issue persists as patients struggle to find which healthcare providers are participating in the program. Meanwhile, the FDA has authorized 115 AI-based medical devices in 2021.

  • 01CMS has initiated the ACCESS pilot program to enhance chronic care management using technology.
  • 02Patients are facing challenges in identifying healthcare providers involved in the ACCESS pilot.
  • 03In 2021, the FDA authorized 115 AI-based medical devices.

Aug 17, 2026

Sobi CEO Guido Oelkers named BioNTech's next chief executive, targeting multiple approved products by 2030

Sobi CEO Guido Oelkers named BioNTech's next chief executive, targeting multiple approved products by 2030

BioNTech has appointed Guido Oelkers, the current CEO of Sobi, as its next chief executive. Oelkers is tasked with advancing BioNTech's oncology pipeline to achieve multiple approved products by 2030.

  • 01BioNTech has selected Guido Oelkers as its new CEO, effective soon.
  • 02Guido Oelkers aims to turn BioNTech's deep oncology pipeline into several approved products by 2030.

Aug 17, 2026

Health systems are spending big on EHRs and AI while governance gaps widen

Health systems are spending big on EHRs and AI while governance gaps widen

Health systems are investing heavily in electronic health records (EHRs) and artificial intelligence (AI). However, there are notable governance gaps in AI implementation in hospitals. Many hospitals lack dedicated platforms for AI testing and reimbursement issues for AI remain unresolved.

  • 01Health systems are making significant financial investments in electronic health records and AI technology.
  • 02AI reimbursement policies remain unclear, posing challenges for healthcare providers.
  • 03Most hospitals do not have dedicated platforms for testing AI applications.

Aug 17, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512